Funding Opportunity

This grant program is designed to support investigators early in their career to derive preliminary data in a key concept area that has high potential to lead to extended funding from NIH, EU, etc.

The objective of this grant is to to explore an innovative concept that has applicability to improving human health. Examples could include fundamental research, clinical research, diagnostic tests, biomarkers, biomedical engineering advances, and imaging advances.

The Disease Model Award is designed to advance the field by developing and validating innovative models to support the scientific community in accelerating discovery. Applications must focus on disease models and their validation. Proposals primarily centered on therapeutic development research are out of scope for this program and will not be reviewed. The goal is to develop, validate, or utilize non-rodent disease models (in silico, in vitro, or in vivo) for therapeutic development for IRD and dAMD.

The purpose of this Notice of Funding Opportunity (FOA) is to enhance mechanistic and epidemiologic investigations addressing the roles of co-infection and cancer to shed light on presently unestablished pathways in carcinogenesis that may inform prevention and treatment strategies for infection-related cancers. Preference will be given to investigations of co-infections with known oncogenic agents (excluding human immunodeficiency virus [HIV]) and of co-infections that engender novel opportunities for prevention and treatment.

This competitive grant program seeks to support independent medical education activities that will increase awareness on the burden of unmet needs in patients with BCG-naive, HR-NMIBC, emerging data and appropriate patient selection and identification.

This award is open to scientists with a PhD or MD, regardless of nationality or location. The Parkinson's Foundation Impact Awards are intended for researchers both established and new to the field of PD.

The Polio Research Committee is calling for research proposals supporting the Polio Endgame Strategy 2022- 2026. Research proposals supporting the strategic plan may be submitted to the Committee for review and funding. Preference will be given to proposals developed by GPEI partner agencies and their research collaborators. However, other institutions may also submit proposals if they address their research priorities.

The purpose of this NOFO is to encourage applications to phenotype and/or perform research on embryonic lethal knockout (KO) mouse strains being generated through the International Mouse Phenotyping Consortium (IMPC) of which the NIH Knockout Mouse Phenotyping Program (KOMP2) is a member. The mission of IMPC is to generate a comprehensive catalogue of mammalian gene function that will provide the foundation for functional analyses of human genetic variation.

This NOFO solicits applications for support of exploratory/developmental studies aimed at accelerating progress toward understanding, preventing or treating Guillain Barre Syndrome (GBS) and/or Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Innovative studies of disease mechanisms, susceptibility factors, model systems, biomarkers and treatments are encouraged.

The National Cancer Institute (NCI) invites grant applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel capabilities for targeting, probing, or assessing molecular and cellular features of cancer biology for basic, clinical, or epidemiological cancer research.

Well-suited applications must propose the development of technologies that offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, cancer control, epidemiology, and/or address issues associated with cancer health disparities. Technologies proposed for development may be intended to have widespread applicability but must be focused on improving molecular and/or cellular characterizations of cancer biology.

Cure SMA encourages applications on novel research that will enhance the understanding of SMA disease pathology at the molecular, cellular, and biochemical level; generate key reagents and tools to facilitate drug development and clinical trials; and identify new therapeutic strategies for SMA. Particular interests exist in understanding mechanisms underlying the pathology of disease and/or identifying drug targets synergistic with SMN-upregulating therapeutics for use in older/symptomatic patients.